Prodromal Dementia with Lewy Bodies: Clinical Characterization and Predictors of Progression.

Publication date: Feb 11, 2020

The objective of this study was to examine clinical characteristics, cognitive decline, and predictors for time to dementia in prodromal dementia with Lewy bodies with mild cognitive impairment (MCI-LB) compared with prodromal Alzheimer’s disease (MCI-AD).

We included 73 MCI-LB patients (12% female; 68?+/-?6?years; Mini Mental State Examination, 27?+/-?2) and 124 MCI-AD patients (48% female; 68?+/-?7?years; Mini Mental State Examination, 27?+/-?2) from the Amsterdam Dementia Cohort. Follow-up was available for 61 MCI-LB patients and all MCI-AD patients (3?+/-?2?years). We evaluated dementia with Lewy bodies core features, neuropsychiatric symptoms, caregiver burden (Zarit caregiver burden interview), MRI, apolipoprotein genotype, and cerebrospinal fluid biomarkers (tau/A? ratio). Longitudinal outcome measures included cognitive slopes (memory, attention, executive functions, and language and visuospatial functions) and time to dementia.

Parkinsonism was the most frequently present core feature in MCI-LB (69%). MCI-LB patients more often had neuropsychiatric symptoms and scored higher on ZARIT when compared with the MCI-AD patients. Linear mixed models showed that at baseline, MCI-LB patients performed worse on nonmemory cognitive domains, whereas memory performance was worse in MCI-AD patients. Over time, MCI-LB patients declined faster on attention, whereas MCI-AD patients declined faster on the Mini Mental State Examination and memory. Cox proportional hazards regressions showed that in the MCI-LB patients, lower attention (hazard ratio [HR] = 1.6; 95% confidence interval [CI], 1.1-2.3) and more posterior cortical atrophy (HR = 3.0; 95% CI, 1.5-5.8) predicted shorter time to dementia. In the MCI-AD patients, worse performance on memory (HR = 1.1; 95% CI, 1.0-1.2) and executive functions (HR = 1.3; 95% CI, 1.0-1.6) were independently associated with time to Alzheimer’s dementia.

MCI-LB patients have distinct neuropsychiatric and cognitive profiles with prominent decline in attention when compared with MCI-AD patients. Our results highlight the importance of early diagnosis because symptoms already have an impact in the prodromal stages. (c) 2020 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Open Access PDF

van de Beek, M., Steenoven, van, van der Zande, J.J., Barkhof, F., Teunissen, C.E., van der Flier, W.M., and Lemstra, A.W. Prodromal Dementia with Lewy Bodies: Clinical Characterization and Predictors of Progression. 23969. 2020 Mov Disord.

Concepts Keywords
Alzheimer Mild cognitive impairment
Amsterdam RTT
Apolipoprotein Dementia
Biomarkers Branches of biology
Caregiver Neuroscience
Cerebrospinal Fluid Learning disabilities
Cognitive Psychiatry
Confidence Interval Cognitive disorders
Dementia Psychiatric diagnosis
Executive Functions Parkinsonism
Genotype Alzheimer’s disease
Lewy Bodies Lewy body
Memory MRI
Mild Cognitive Impairment Genotype
Movement Disorders
Wiley Periodicals Inc


Type Source Name
disease MESH Dementia
disease MESH cognitive decline
disease MESH atrophy
disease MESH diagnosis
disease MESH Movement Disorders


Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *